National Comprehensive Cancer Network

Chemotherapy Order Template

Kidney Cancer

Gemcitabine/CARBOplatin

 KDN5

INDICATION:

Metastatic or Relapsed – Collecting Duct/Medullary Subtypes

REFERENCES:

  1. NCCN Guidelines® for Kidney Cancer. V.3.2015.
  2. Oudard S, et al. J Urol. 2007;177(5):1698-702. a

NCCN SUPPORTIVE CARE:

  1. Emetic Risk:
    Day 1 Moderate
    Day 8 Low
  2. Fever Neutropenia Risk:
    Refer to NCCN Guidelines for Myeloid Growth Factors. V.2.2014

CHEMOTHERAPY REGIMEN

21-day cycle for 6 cycles

  • Gemcitabine 1250 mg/m 2 IV over 30 minutes on Days 1 and 8
  • CARBOplatin AUC 5 IV over 30 minutes on Day 1
<type><text value="Chemotherapy Order Template"/></type><status value="draft"/><experimental value="true"/><publisher value="National Comprehensive Cancer Network, Inc."/><description value="Gemcitabine/CARBOplatin"/><useContext><extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"><valueString value="A"/></extension><code><system value="http://example.org/fhir/CodeSystem/indications"/><code value="treamentSetting-or-diseaseStatus"/></code><valueCodeableConcept><text value="Metastatic"/></valueCodeableConcept></useContext><useContext><extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"><valueString value="A"/></extension><code><system value="http://example.org/fhir/CodeSystem/indications"/><code value="disease-or-histology"/></code><valueCodeableConcept><text value="Collecting Duct/Medullary Subtypes"/></valueCodeableConcept></useContext><useContext><extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"><valueString value="A"/></extension><code><system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/><code value="focus"/></code><valueCodeableConcept><text value="Kidney Cancer"/></valueCodeableConcept></useContext><useContext><extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"><valueString value="B"/></extension><code><system value="http://example.org/fhir/CodeSystem/indications"/><code value="treatmentSetting-or-diseaseStatus"/></code><valueCodeableConcept><text value="Relapsed"/></valueCodeableConcept></useContext><useContext><extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"><valueString value="B"/></extension><code><system value="http://example.org/fhir/CodeSystem/indications"/><code value="disease-or-histology"/></code><valueCodeableConcept><text value="Collecting Duct/Medullary Subtypes"/></valueCodeableConcept></useContext><useContext><extension url="http://hl7.org/fhir/StructureDefinition/usagecontext-group"><valueString value="B"/></extension><code><system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/><code value="focus"/></code><valueCodeableConcept><text value="Kidney Cancer – Collecting Duct/Medullary Subtypes - Metastatic"/></valueCodeableConcept></useContext><copyright value="All rights reserved."/><approvalDate value="2016-07-27"/><lastReviewDate value="2016-07-27"/><author><name value="Lee Surprenant"/></author><relatedArtifact><type value="derived-from"/><display value="NCCN Guidelines for Kidney Cancer. V.2.2016"/><document><url value="http://www.example.org/professionals/physician_gls/PDF/kidney.pdf"/></document></relatedArtifact><relatedArtifact><type value="citation"><extension url="http://example.org/fhir/regimenReferenceType"><valueCode value="a"/></extension></type><citation value="Oudard S, et al. J Urol. 2007;177(5):1698-702"/><document><url value="http://www.ncbi.nlm.nih.gov/pubmed/17437788"/></document></relatedArtifact><action><selectionBehavior value="exactly-one"/><action><selectionBehavior value="all"/><action><groupingBehavior value="sentence-group"/><selectionBehavior value="exactly-one"/><action id="cycle-definition-1"><textEquivalent value="21-day cycle for 6 cycles"/><timingTiming><repeat><count value="6"/><duration value="21"/><durationUnit value="d"/></repeat></timingTiming><action id="action-1"><extension url="http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"><extension url="day"><valueInteger value="1"/></extension><extension url="day"><valueInteger value="8"/></extension></extension><textEquivalent value="Gemcitabine 1250 mg/m² IV over 30 minutes on days 1 and 8"/><definitionCanonical value="#1111"/></action><action id="action-2"><extension url="http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"><extension url="day"><valueInteger value="1"/></extension></extension><textEquivalent value="CARBOplatin AUC 5 IV over 30 minutes on Day 1"/><relatedAction><targetId value="action-1"/><relationship value="concurrent-with-start"/></relatedAction><definitionCanonical value="#2222"/></action></action></action></action></action></PlanDefinition>